Menu Search
Equities

Nordhealth AS

NRDHF:PNK

Nordhealth AS

Actions
  • Price (USD)--
  • Today's Change--
  • Shares traded600.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Nordhealth AS grew revenues 18.60% from 31.05m to 36.83m while net income improved from a loss of 14.26m to a smaller loss of 11.13m.
Gross margin85.82%
Net profit margin-22.59%
Operating margin-23.54%
Return on assets-9.78%
Return on equity-11.16%
Return on investment-11.11%
More ▼

Cash flow in EURView more

In 2023, cash reserves at Nordhealth AS fell by 10.46m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 5.22m for operations while cash used for investing totalled 2.63m.
Cash flow per share0.2186
Price/Cash flow per share100.08
Book value per share11.63
Tangible book value per share2.95
More ▼

Balance sheet in EURView more

Nordhealth AS has little financial risk as the capital structure does not rely on leverage.
Current ratio2.77
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in EUR

SmartText is unavailable
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		--
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.